logo

For the Inventor, By the Inventor

Shenzhen, China

Shenzhen Chipscreen Biosciences, Ltd.


USPTO Granted Patents = 12



Trademarks = 1

Forward Citations = 41

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Zhibin Li (8 out of 20 patents)

silverMedal Song Shan (7 out of 9 patents)

bronzeMedal Xian-Ping Lu (7 out of 8 patents)

4.  Zhiqiang Ning (6 out of 7 patents)

5.  Xianping Lu (5 out of 12 patents)

6.  Jindi Yu (3 out of 4 patents)

7.  Zhi-Bin Li (3 out of 3 patents)

8.  Zhi-Qiang Ning (3 out of 3 patents)

9.  Leming Shi (3 out of 4 patents)

10.  Tuo Deng (3 out of 5 patents)

11.  Qianjiao Yang (2 out of 4 patents)

12.  Jiangfei Zhu (2 out of 3 patents)

13.  Desi Pan (2 out of 3 patents)

14.  Aihua Xie (2 out of 2 patents)

15.  Boyu Li (2 out of 2 patents)


12 patents:

1. 12653817 - Pharmaceutical composition comprising protein kinase inhibitor and chemotherapeutic drug and use thereof (2026-06-16),
2. 12577260 - Biphenyl compound as immunomodulator, preparation method therefor and application thereof (2026-03-17),
3. 12551478 - Quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity (2026-02-17),
4. 10011571 - Preparation method for aromatic heterocyclic compound used as selective JAK3 and/or JAK1 kinase inhibitor and application of aromatic heterocyclic compound (2018-07-03),
5. 9573901 - Crystal form of chidamide, preparation method and use thereof (2017-02-21),
6. 8211901 - Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors (2012-07-03),
7. 8178577 - Tricyclic derivatives as potent and selective histone deacetylase inhibitors (2012-05-15),
8. 8158656 - 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors (2012-04-17),
9. 7863315 - 2-indolinone derivatives as selective histone deacetylase inhibitors (2011-01-04),
10. 7550490 - Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity (2009-06-23),
11. 7268157 - Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity (2007-09-11),
12. 7244751 - Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity (2007-07-17),
Company Overview
Shenzhen Chipscreen Biosciences, Ltd. is a biotechnology company based in Shenzhen, China, specializing in the research, development, and commercialization of innovative therapeutics. The company focuses on areas such as oncology and autoimmune diseases, leveraging advanced technologies to create novel drug candidates. Chipscreen is committed to enhancing patient outcomes through its cutting-edge solutions, contributing to the global biopharmaceutical landscape with a strong emphasis on scientific excellence and collaboration.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#375 in Shenzhen

#2,357 in China

#48,163 in the World

Shenzhen, CN
Shenzhen, China

Shenzhen Chipscreen Biosciences, Ltd.

Forward Citations = 41

32 inventors:

goldMedal Zhibin Li (8 out of 20 patents)

silverMedal Song Shan (7 out of 9 patents)

bronzeMedal Xian-Ping Lu (7 out of 8 patents)

4.  Zhiqiang Ning (6 out of 7 patents)

5.  Xianping Lu (5 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shenzhen Chipscreen Biosciences, Ltd.. Retrieved from https://idiyas.com/company/shenzhen-chipscreen-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…